Skip to Content

J 248 (Lamotrigine 200 mg)

Pill with imprint J 248 is White, Round and has been identified as Lamotrigine 200 mg. It is supplied by Cadista.

Lamotrigine is used in the treatment of bipolar disorder; schizoaffective disorder; seizure prevention; epilepsy and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for J 248

Lamotrigine 200 mg J 248
Lamotrigine 200 mg J 248
Lamotrigine 200 mg J 248
Lamotrigine 200 mg J 248
Lamotrigine 200 mg J 248
Lamotrigine 200 mg J 248

Lamotrigine

Imprint
J 248
Strength
200 mg
Color
White
Size
13.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Triazine anticonvulsants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cadista
Inactive Ingredients
lactose monohydrate, magnesium stearate, microcrystalline cellulose, sodium starch glycolate type A potato

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
59746-0248 Jubilant Cadista Pharmaceuticals Inc.
42291-0369 AvKare, Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.